Cefixime is a semi-synthetic, third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, leading to cell death in susceptible organisms. It is stable against many beta-lactamase enzymes produced by resistant bacteria, which broadens its spectrum of activity compared to earlier-generation cephalosporins.

AAYUCEF 200 is manufactured under WHO-GMP compliant conditions with strict batch-wise quality control, ensuring consistent potency and bioavailability across every pack dispatched to partners.

Cefixime is a semi-synthetic, third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, leading to cell death in susceptible organisms. It is stable against many beta-lactamase enzymes produced by resistant bacteria, which broadens its spectrum of activity compared to earlier-generation cephalosporins.

AAYUCEF 200 is manufactured under WHO-GMP compliant conditions with strict batch-wise quality control, ensuring consistent potency and bioavailability across every pack dispatched to partners.

Cefixime is a semi-synthetic, third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, leading to cell death in susceptible organisms. It is stable against many beta-lactamase enzymes produced by resistant bacteria, which broadens its spectrum of activity compared to earlier-generation cephalosporins.

AAYUCEF 200 is manufactured under WHO-GMP compliant conditions with strict batch-wise quality control, ensuring consistent potency and bioavailability across every pack dispatched to partners.